The drug, in phase 3 of clinical research, is as effective and safe as raltegravir and offers more resistance to virus mutations 800 patients Article reference
A high adherence to the Mediterranean diet reduces the risk of breast cancer by 6% in women in general, and by 7% in post-menopausal women. The EPIC Project Mediterranean diet and breast cancer Reference Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study.
Manel Esteller, Director of the Cancer Epigenetics and Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Research Professor and Genetics Professor of the University of Barcelona has been appointed Associate Editor of The Journal of the National Cancer Institute (JNCI). The journal publishes peer-reviewed original research from around the world and is internationally …